Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

Overview of attention for article published in Lancet Oncology, December 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 31,941 followers.

Lancet Oncology。臓器移植後CD20陽性B細胞リンパ増殖性疾患にリツキシマブ4コース→CHOP4コース。こういう発想もあるのか。成績は良いが、G-CSFと予防的抗生剤を使用して治療関連死11%。元々の状態が厳しいんだろうな。 http://t.co/aee8nGBd

[Articles] Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transp... http://t.co/5rZS5K5S #cancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.